From September 9 to 13, 2026, the China International Fair for Trade in Services (CIFTIS), themed "Global Services, Mutual Benefits and Shared Prosperity," was grandly held at Shougang Park in Beijing. Hangzhou NEUREAL Technology Co., Ltd. unveiled its independently developed non-invasive BCI closed-loop psychiatric care system, showcasing cutting-edge breakthroughs in Chinese brain science through the clinical translation of non-invasive brain-computer interface technology.
Selected for the Frontier Zone, Anchoring New Coordinates for Future Healthcare
As the first national-level comprehensive service trade exhibition in the inaugural year of the "15th Five-Year Plan," this CIFTIS attracted exhibitions from 90 countries and international organizations, with over 1,800 companies participating offline. Among them, the "Future Medical Technology Industry Frontier Zone," newly established within the Health and Hygiene Services Special Exhibition Area, drew the most attention. This zone specifically featured eight innovative SMEs in frontier fields such as precision medicine, Brain-Computer Interface (BCI), and cell therapy, providing a dedicated space for display, negotiation, and cooperation for growing tech teams. NEUREAL's selection serves as authoritative recognition of its technological leadership and clinical implementation capabilities in the field of non-invasive BCI.
Focusing on Emotion and Cognition Decoding, Establishing a Full-Process Closed Loop for Brain Health Services
As a National Specialized, Refined, Distinctive, and Innovative "Little Giant" enterprise focused on non-invasive Brain-Computer Interface (BCI), NEUREAL has developed a non-invasive BCI closed-loop neuromodulation solution centered on emotion and cognition decoding. It serves populations with brain function disorders such as depression, ADHD, autism, and cognitive decline, building a full-process brain health service chain covering "screening—assessment—intervention—management."
At the exhibition venue, crowds surged as NEUREAL's booth hosted visitors from domestic and international medical institutions and overseas service providers. Many guests experienced EEG acquisition and VR cognitive rehabilitation training on-site, engaging in in-depth discussions on clinical implementation details and technical pathways. Several industry experts showed high interest in the product's potential for clinical translation and industrialization path.
Deepening Industry-Academia-Research-Medicine Collaboration, Jointly Building a BCI Rehabilitation Ecosystem
This CIFTIS provided an important opportunity for NEUREAL to showcase the strength of domestic non-invasive BCI innovation to the world. Leveraging the international platform of CIFTIS, the company will continue to connect with global healthcare resources, deepen international collaboration among industry, academia, research, and medicine, promote the widespread clinical application of BCI technology, and contribute Chinese-style innovative solutions to the global field of psychiatric care and cognitive rehabilitation.
